This article is concerned with issues pertaining to the degree to which clinical therapeutic decisions can reasonably depart from the best available scientific data.
There is a tension between the traditions of practitioner autonomy and the boundaries set by research findings.
Ambiguity exists as to how much freedom practitioners have to accept or reject the existing scientific paradigm.
The nature of the dilemma is explored by analyzing the current problems confronting child psychiatrists and pediatricians who choose to treat depressed children with antidepressants.
Despite unanimous literature of double-blind studies indicating that antidepressants are no more effective than placebos in treating depression in children and adolescents, such medications continue to be in wide use.
The strategies used to resolve this sort of contradiction are considered, and certain ethical puzzles are appraised.
Mots-clés Pascal : Etat dépressif, Trouble humeur, Enfant, Homme, Adolescent, Prescription médicale, Antidépresseur, Psychotrope, Chimiothérapie, Efficacité traitement, Recherche scientifique, Psychiatre, Pédiatrie, Personnel sanitaire, Santé publique
Mots-clés Pascal anglais : Depression, Mood disorder, Child, Human, Adolescent, Medical prescription, Antidepressant agent, Psychotropic, Chemotherapy, Treatment efficiency, Scientific research, Psychiatrist, Pediatrics, Health staff
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0154306
Code Inist : 002B02B02. Création : 199608.